340B hospitals and health centers say they have a lot of questions about new requests from Express Scripts (ESI) to verify 340B drug reimbursement claims in 10 business days.
Category: Other Industry
Signify Health, a value-based healthcare platform with a network of over 3,000 physician practices and facilities, has signed an agreement to acquire Caravan Health, a company that helps hospitals and health systems with value-based care arrangements maximize 340B savings, the
…
Michelle Wiest, most recently vice president of pharmacy services at UC Health in Cincinnati, is Apexus’s new senior vice president of 340B policy and compliance.
Please Login or Become a Paid Subscriber to View this Content
Health care services and group purchasing company Vizient asked Congress on Monday to pass the U.S. Senate version of bipartisan legislation to protect hospitals from losing their 340B eligibility due to changes in patient and payer mix caused by the
…
Boston-based par8o, which provides 340B services including a platform to help 340B covered entities manage their patient referral claims, has been acquired by Cloudmed.
Please Login or Become a Paid Subscriber to View this Content
Pharmacy automation, 340B compliance, and medication management company Omnicell is acquiring ReCept Holdings, which helps hospitals, health centers, Ryan White Clinics, and other providers open and manage in-house 340B pharmacies and specialty pharmacies.
Please Login or
Kaiser Health News (KHN), a nonprofit health care news organization whose stories are widely and freely republished and rebroadcast, released an in-depth article and news video today about the 340B program and the fight over 340B contract pharmacy.
…
Sectyr, an established provider of compliance platforms for 340B covered entities, has acquired LicenseTrak, a system for managing license, contract, training, and other business tasks, the companies announced last week.
Please Login or Become a Paid
After an initial burst of optimism earlier this year, some health care organizations are having second thoughts about large in-person events for the remainder of 2021 and the start of the new year.
Please Login or
In his latest column for Omnicell, 340B Report Publisher and CEO Ted Slafsky ponders four burning questions as we approach the first anniversary of drug manufacturers stopping or placing restrictions on 340B drug discounts in the contract pharmacy setting. …